Report overview
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Drugs. This report contains market size and forecasts of Ophthalmic Drugs in global, including the following market information:
Global Ophthalmic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ophthalmic Drugs Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Ophthalmic Drugs companies in 2022 (%)
The global Ophthalmic Drugs market was valued at US$ 22950 million in 2022 and is projected to reach US$ 26720 million by 2029, at a CAGR of 2.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
We surveyed the Ophthalmic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Ophthalmic Drugs Market Segment Percentages, by Type, 2022 (%)
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Global Ophthalmic Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Ophthalmic Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Pharmacy
Global Ophthalmic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Ophthalmic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ophthalmic Drugs revenues share in global market, 2022 (%)
Key companies Ophthalmic Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Ophthalmic Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Santen Pharmaceutical
Bausch Health
Takeda
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Drugs, market overview.
Chapter 2: Global Ophthalmic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
